Single-Cell Profiling of Tumor Immune Microenvironment Reveals Immune Irresponsiveness in Gastric Signet-Ring Cell Carcinoma

被引:40
|
作者
Chen, Jing [1 ]
Liu, Kuai [2 ,3 ,4 ,5 ]
Luo, Yikai [6 ,7 ]
Kang, Muxing [1 ]
Wang, Jun [1 ]
Chen, Guofeng [1 ]
Qi, Jia [1 ]
Wu, Wenxuan [1 ]
Wang, Beidi [1 ]
Han, Yaxuan [1 ]
Shi, Le [1 ]
Wang, Kefan [1 ]
Han, Xiaying [1 ]
Ma, Xiaojing [8 ]
Liu, Wei [7 ]
Ding, Yuan [9 ]
Wang, Liangjing [5 ,10 ]
Liang, Han [6 ,7 ,11 ,14 ]
Wang, Lie [2 ,3 ,4 ,5 ,13 ]
Chen, Jian [1 ,12 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Gastrointestinal Surg, Hangzhou, Peoples R China
[2] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China
[4] Zhejiang Univ, Med Ctr, Liangzhu Lab, Hangzhou, Peoples R China
[5] Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China
[6] Baylor Coll Med, Grad Program Quantitat & Computat Biosci, Houston, TX USA
[7] Univ Texas, MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX USA
[8] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Pathol, Hangzhou, Peoples R China
[9] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Surg, Hangzhou, Peoples R China
[10] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Gastroenterol, Hangzhou, Peoples R China
[11] Univ Texas, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX USA
[12] 88 Jiefang Rd, Hangzhou 310009, Peoples R China
[13] 866 Yuhangtang Rd, Hangzhou 310058, Peoples R China
[14] 1400 Pressler St, Houston, TX 77030 USA
基金
中国国家自然科学基金;
关键词
Gastric Cancer; T-Cell State; CXCL13; Immune Checkpoint Blockade; ACTIVATION; EXPRESSION; HETEROGENEITY; AUTOIMMUNITY;
D O I
10.1053/j.gastro.2023.03.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Gastric cancer (GC) is a major cancer type characterized by high heterogeneity in both tumor cells and the tumor immune microenvironment (TIME). One intractable GC subtype is gastric signet-ring cell carcinoma (GSRCC), which is associated with poor prognosis. However, it remains unclear what the GSRCC TIME characteristics are and how these characteristics may contribute to clinical outcomes.METHODS: We enrolled 32 patients with advanced GC of diverse subtypes and profiled their TIME using an immune targeted single-cell profiling strategy, including (1) immune targeted single-cell RNA sequencing (n = 20 patients) and (2) protein expression profiling by a targeted antibody panel for mass cytometry (n = 12 patients). We also generated matched V(D)J (variable, diversity, and joining gene segments) sequencing of T and B cells along CD45+ immunocytes.RESULTS: We found that compared to non-GSRCC, the GSRCC TIME appears to be quiescent, where both CD4+ and CD8+ T cells are difficult to be mobilized, which further impairs the proper functions of B cells. CXCL13, mainly produced by follicular helper T cells, T helper type 17, and exhausted CD8+ T cells, is a central coordinator of this transformation. We show that CXCL13 expression can predict the response to immune checkpoint blockade in GC patients, which may be related to its effects on tertiary lymphoid structures.CONCLUSIONS: Our study provides a comprehensive molecular portrait of immune cell compositions and cell states in advanced GC patients, highlighting adaptive immune irresponsiveness in GSRCC and a mediator role of CXCL13 in TIME. Our targeted single-cell transcriptomic and proteomic profiling represents a powerful approach for TIME-oriented translational research.
引用
收藏
页码:88 / 103
页数:16
相关论文
共 50 条
  • [21] Signet-ring cell change versus signet-ring cell carcinoma - A comparative analysis
    Wang, K
    Weinrach, D
    Lal, A
    Musunuri, S
    Ramirez, J
    Ozer, O
    Keh, P
    Rao, MS
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (11) : 1429 - 1433
  • [22] SINGLE CELL TRANSCRIPTIONAL PROFILING OF IMMUNE POPULATIONS WITHIN RENAL CELL CARCINOMA TUMOR MICROENVIRONMENT
    Wang, Vinson
    Obradovic, Aleksandar
    Chowdhury, Nivedita
    Aggen, David
    Bush, Erin
    Decastro, Guarionex Joel
    Anderson, Christopher B.
    McKiernan, James M.
    Ding, Hongxu
    Sims, Peter
    Califano, Andrea
    Drake, Charles G.
    JOURNAL OF UROLOGY, 2019, 201 (04): : E292 - E292
  • [23] Signet-ring cell basal cell carcinoma
    Roh, Mi Ryung
    Kwon, Ji Eun
    Lee, Kwang Gil
    Lee, Ju Hee
    JOURNAL OF CUTANEOUS PATHOLOGY, 2010, 37 (11) : 1188 - 1189
  • [24] Gastric Signet-Ring Cell Carcinoma With Multiple Colorectal Metastases
    Mao, Yanhui
    Ye, Liansong
    Wang, Fanrong
    Qin, Jiamin
    Wen, Liming
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (03): : 410 - 410
  • [25] Signet-ring cell carcinoma in gastric biopsies: expecting the unexpected
    Golembeski, Christopher P.
    Genta, Robert Maximilian
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (02) : 136 - 139
  • [26] Signet-Ring Cell Carcinoma of the Gallbladder after Gastric Bypass
    Justin A. Snyder
    Robert Carman
    Luciano DiMarco
    Journal of Gastrointestinal Cancer, 2012, 43 (Suppl 1) : 67 - 69
  • [27] Livedoid cutaneous metastasis of signet-ring cell gastric carcinoma
    Demircioglu, Deniz
    Ozturk Durmaz, Emel
    Demirkesen, Cuyan
    Sahin, Sedef
    JOURNAL OF CUTANEOUS PATHOLOGY, 2021, 48 (06) : 785 - 788
  • [28] PROFILING THE TUMOR IMMUNE MICROENVIRONMENT OF PAPILLARY RENAL CELL CARCINOMA
    Mitch, Hayes
    Kirill, Sabitov
    Alex, Soupir
    Taylor, Peak
    Jonathan, Nguyen
    Carlos, Moran-Segura
    Daryoush, Saeed-Vafa
    Neale, Lopez-Blanco
    Ramos, Echevarria Paola M.
    Jodi, Balasi
    Jasreman, Dhillon
    Youngchul, Kim
    James, Mule
    Brooke, Fridley
    Brandon, Manley
    Christopher, Guske
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S6 - S6
  • [29] Signet-ring cell carcinoma of the breast
    Liu, SM
    Chen, DR
    PATHOLOGY INTERNATIONAL, 2000, 50 (01) : 67 - 70
  • [30] Metastatic breast carcinoma and Krukenberg tumor from signet-ring cell gastric cancer
    Wan, Jiangyang
    Feng, Ziyu
    Shi, Jianhua
    Li, Qiang
    ASIAN JOURNAL OF SURGERY, 2023, 46 (07) : 2984 - 2986